| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 11 5280-5288, Copyright © 1995 by American Association of Immunologists
ARTICLES |
WR Force, BN Walter, C Hession, R Tizard, CA Kozak, JL Browning and CF Ware
Division of Biomedical Sciences, University of California, Riverside 92521, USA.
Lymphotoxin (LT) -alpha beta heterotrimer is a membrane-anchored ligand expressed by activated T cells which binds specifically to the LT beta receptor (LT beta R), a member of the TNFR family. The LT beta R is implicated as a critical element in controlling lymph node development and cellular immune reactions. To address this hypothesis we have isolated a mouse cDNA encoding a single transmembrane protein of 415 amino acids with 76% identity to human LT beta R. The receptor function of this molecule was demonstrated by the ability of the extracellular domain, constructed as a chimera with the Fc region of IgG7, to bind to LT alpha beta complexes expressed on the surface of activated T cells or insect cells infected with baculoviruses containing LT alpha and LT beta cDNAs. The gene encoding mouse LT beta R, Ltbr, contains 10 exons spanning 6.9 kb and maps to mouse chromosome 6, which is closely linked to Tnfr1, consistent with the tight linkage of the human homologue of these genes on chromosome 12p13. Mouse LT beta R mRNA is expressed by cell lines of monocytic and epithelial origin but not by a CTL line, and in vivo it is constitutively expressed in visceral and lymphoid tissues. The delineation of the structure of the mouse LT beta R will aid investigations into the role of this cytokine-receptor system in immune function and development.
This article has been cited by other articles:
|
|
 |
|
  M. Heikenwalder, M. Prinz, N. Zeller, K. S. Lang, T. Junt, S. Rossi, A. Tumanov, H. Schmidt, J. Priller, L. Flatz, et al. Overexpression of Lymphotoxin in T Cells Induces Fulminant Thymic Involution Am. J. Pathol., June 1, 2008; 172(6): 1555 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Xu, D. Liu, I. Okwor, Y. Wang, H. Korner, S. K. P. Kung, Y.-X. Fu, and J. E. Uzonna LIGHT Is Critical for IL-12 Production by Dendritic Cells, Optimal CD4+ Th1 Cell Response, and Resistance to Leishmania major J. Immunol., November 15, 2007; 179(10): 6901 - 6909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Ferry, M. Anderson, K. Beddard, S. Tomlinson, P. Atherfold, J. Obszynska, R. Harrison, and J. Jankowski A Phase II Study of Gefitinib Monotherapy in Advanced Esophageal Adenocarcinoma: Evidence of Gene Expression, Cellular, and Clinical Response Clin. Cancer Res., October 1, 2007; 13(19): 5869 - 5875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Glaysher and N. A. Mabbott Role of the GALT in Scrapie Agent Neuroinvasion from the Intestine J. Immunol., March 15, 2007; 178(6): 3757 - 3766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anders, S. K. Subudhi, J. Wang, K. Pfeffer, and Y.-X. Fu Contribution of the Lymphotoxin {beta} Receptor to Liver Regeneration J. Immunol., July 15, 2005; 175(2): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang, R. A. Anders, Y. Wang, J. R. Turner, C. Abraham, K. Pfeffer, and Y.-X. Fu The Critical Role of LIGHT in Promoting Intestinal Inflammation and Crohn's Disease J. Immunol., June 15, 2005; 174(12): 8173 - 8182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mortarini, A. Scarito, D. Nonaka, M. Zanon, I. Bersani, E. Montaldi, E. Pennacchioli, R. Patuzzo, M. Santinami, and A. Anichini Constitutive Expression and Costimulatory Function of LIGHT/TNFSF14 on Human Melanoma Cells and Melanoma-Derived Microvesicles Cancer Res., April 15, 2005; 65(8): 3428 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-N. Kweon, M. Yamamoto, P. D. Rennert, E. J. Park, A.-Y. Lee, S.-Y. Chang, T. Hiroi, M. Nanno, and H. Kiyono Prenatal Blockage of Lymphotoxin {beta} Receptor and TNF Receptor p55 Signaling Cascade Resulted in the Acceleration of Tissue Genesis for Isolated Lymphoid Follicles in the Large Intestine J. Immunol., April 1, 2005; 174(7): 4365 - 4372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Kim, S. A. Nedospasov, and Z.-g. Liu TRAF2 Plays a Key, Nonredundant Role in LIGHT-Lymphotoxin {beta} Receptor Signaling Mol. Cell. Biol., March 15, 2005; 25(6): 2130 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamamoto, M.-N. Kweon, P. D. Rennert, T. Hiroi, K. Fujihashi, J. R. McGhee, and H. Kiyono Role of Gut-Associated Lymphoreticular Tissues in Antigen-Specific Intestinal IgA Immunity J. Immunol., July 15, 2004; 173(2): 762 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Stopfer, D. N. Mannel, and T. Hehlgans Lymphotoxin-{beta} Receptor Activation by Activated T Cells Induces Cytokine Release from Mouse Bone Marrow-Derived Mast Cells J. Immunol., June 15, 2004; 172(12): 7459 - 7465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Elewaut, R. B. Shaikh, K. J. L. Hammond, H. De Winter, A. J. Leishman, S. Sidobre, O. Turovskaya, T. I. Prigozy, L. Ma, T. A. Banks, et al. NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of V{alpha}14i NKT Cells J. Exp. Med., June 16, 2003; 197(12): 1623 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Mabbott, J. Young, I. McConnell, and M. E. Bruce Follicular Dendritic Cell Dedifferentiation by Treatment with an Inhibitor of the Lymphotoxin Pathway Dramatically Reduces Scrapie Susceptibility J. Virol., June 15, 2003; 77(12): 6845 - 6854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ehlers, C. Holscher, S. Scheu, C. Tertilt, T. Hehlgans, J. Suwinski, R. Endres, and K. Pfeffer The Lymphotoxin {beta} Receptor Is Critically Involved in Controlling Infections with the Intracellular Pathogens Mycobacterium tuberculosis and Listeria monocytogenes J. Immunol., May 15, 2003; 170(10): 5210 - 5218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Drayton, X. Ying, J. Lee, W. Lesslauer, and N. H. Ruddle Ectopic LT{alpha}{beta} Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase J. Exp. Med., May 5, 2003; 197(9): 1153 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Chen, M.-J. Hwang, Y.-C. Chou, W.-H. Chen, G. Cheng, H. Nakano, T.-Y. Luh, S.-C. Mai, and S.-L. Hsieh The Role of Apoptosis Signal-regulating Kinase 1 in Lymphotoxin-beta Receptor-mediated Cell Death J. Biol. Chem., April 25, 2003; 278(18): 16073 - 16081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wang and Y.-X. Fu LIGHT (a Cellular Ligand for Herpes Virus Entry Mediator and Lymphotoxin Receptor)-Mediated Thymocyte Deletion Is Dependent on the Interaction Between TCR and MHC/Self-Peptide J. Immunol., April 15, 2003; 170(8): 3986 - 3993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hehlgans, B. Stoelcker, P. Stopfer, P. Muller, G. Cernaianu, M. Guba, M. Steinbauer, S. A. Nedospasov, K. Pfeffer, and D. N. Mannel Lymphotoxin-{beta} Receptor Immune Interaction Promotes Tumor Growth by Inducing Angiogenesis Cancer Res., July 15, 2002; 62(14): 4034 - 4040. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Browning and L. E. French Visualization of Lymphotoxin-{beta} and Lymphotoxin-{beta} Receptor Expression in Mouse Embryos J. Immunol., May 15, 2002; 168(10): 5079 - 5087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Mabbott and M. E. Bruce The immunobiology of TSE diseases J. Gen. Virol., October 1, 2001; 82(10): 2307 - 2318. [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshida, H. Kawamoto, S. M. Santee, H. Hashi, K. Honda, S. Nishikawa, C. F. Ware, Y. Katsura, and S.-I. Nishikawa Expression of {alpha}4{beta}7 Integrin Defines a Distinct Pathway of Lymphoid Progenitors Committed to T Cells, Fetal Intestinal Lymphotoxin Producer, NK, and Dendritic Cells J. Immunol., September 1, 2001; 167(5): 2511 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dohi, P. D. Rennert, K. Fujihashi, H. Kiyono, Y. Shirai, Y. I. Kawamura, J. L. Browning, and J. R. McGhee Elimination of Colonic Patches with Lymphotoxin {beta} Receptor-Ig Prevents Th2 Cell-Type Colitis J. Immunol., September 1, 2001; 167(5): 2781 - 2790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Weih, Z. B. Yilmaz, and F. Weih Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines J. Immunol., August 15, 2001; 167(4): 1909 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujihashi, T. Dohi, P. D. Rennert, M. Yamamoto, T. Koga, H. Kiyono, and J. R. McGhee Peyer's patches are required for oral tolerance to proteins PNAS, March 13, 2001; 98(6): 3310 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamamoto, P. Rennert, J. R. McGhee, M.-N. Kweon, S. Yamamoto, T. Dohi, S. Otake, H. Bluethmann, K. Fujihashi, and H. Kiyono Alternate Mucosal Immune System: Organized Peyer's Patches Are Not Required for IgA Responses in the Gastrointestinal Tract J. Immunol., May 15, 2000; 164(10): 5184 - 5191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Herrera, D. M. Harlan, and P. Vassalli A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: Possible role of membrane TNF PNAS, January 4, 2000; 97(1): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Matsumoto, K. Iwamasa, P. D. Rennert, T. Yamada, R. Suzuki, A. Matsushima, M. Okabe, S. Fujita, and M. Yokoyama Involvement of Distinct Cellular Compartments in the Abnormal Lymphoid Organogenesis in Lymphotoxin-{alpha}-Deficient Mice and Alymphoplasia (aly) Mice Defined by the Chimeric Analysis J. Immunol., August 1, 1999; 163(3): 1584 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Wu, P.-Y. Wang, S.-H. Han, and S.-L. Hsieh The Cytoplasmic Domain of the Lymphotoxin-{beta} Receptor Mediates Cell Death in HeLa Cells J. Biol. Chem., April 23, 1999; 274(17): 11868 - 11873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. N. Ngo, H. Korner, M. D. Gunn, K. N. Schmidt, D. Sean Riminton, M. D. Cooper, J. L. Browning, J. D. Sedgwick, and J. G. Cyster Lymphotoxin alpha /beta and Tumor Necrosis Factor Are Required for Stromal Cell Expression of Homing Chemokines in B and T Cell Areas of the Spleen J. Exp. Med., January 18, 1999; 189(2): 403 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Endres, M. B. Alimzhanov, T. Plitz, A. Futterer, M. H. Kosco-Vilbois, S. A. Nedospasov, K. Rajewsky, and K. Pfeffer Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin beta Receptor by Radioresistant Stromal Cells and of Lymphotoxin beta and Tumor Necrosis Factor by B Cells J. Exp. Med., January 4, 1999; 189(1): 159 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Force, T. C. Cheung, and C. F. Ware Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-beta Receptor J. Biol. Chem., December 5, 1997; 272(49): 30835 - 30840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ettinger, J. L. Browning, S. A. Michie, W. van Ewijk, and H. O. McDevitt Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein PNAS, November 12, 1996; 93(23): 13102 - 13107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nakano, H. Oshima, W. Chung, L. Williams-Abbott, C. F. Ware, H. Yagita, and K. Okumura TRAF5, an Activator of NF-kappa B and Putative Signal Transducer for the Lymphotoxin-beta Receptor J. Biol. Chem., June 21, 1996; 271(25): 14661 - 14664. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
